E

Emoscience

BE0535.540.166

Gross margin
€ 13K ↓ 59% 2025 Total € 325K
Profit
€ -381 ↓ 103% 2025 Total € 178K
EBITDA
€ 13K ↓ 58% 2025 Total € 318K
EBIT
€ 743 ↓ 96% 2025 Total € 287K
Net profit
€ -381 ↓ 103% 2025 Total € 178K
Capex
€ 0 ↓ 100% 2025 Total € 53K
Assets
€ 166K ↑ 3% 2025
Equity
€ 98K ↓ 30% 2025
Debt
€ 68K ↑ 237% 2025
Cash
€ 103K ↑ 34% 2025
Cashflow
€ 11K ↓ 55% 2025 Total € 209K
Working capital
€ 69K ↓ 31% 2025
Current ratio
2.02 ↓ 66% 2025
Quick ratio
2.02 ↓ 66% 2025
Working capital ratio
2.02 ↓ 66% 2025
Debt
€ 68K ↑ 237% 2025
Short-term debt
€ 68K ↑ 237% 2025
Debt / EBITDA
5.42 ↑ 709% 2025
Solvability
59.1% ↓ 28.4 pt 2025
Gross profitability
11.6% ↓ 6.6 pt 2025
Net profitability
-0.4% ↓ 10.3 pt 2025
Return On Assets (ROA)
-0.23 ↓ 103% 2025
Return On Equity (ROE)
-0.39 ↓ 104% 2025
Taxes
€ 3K ↓ 38% 2025 Total € 110K
Salaries and Social Security Contributions
€ 24K ↑ 61% 2025 Total € 39K
Dividends
€ 42K ↑ 600% 2025 Total € 93K
Dividend payout
14.8% ↓ 9.1 pt 2019